DSG Global Enters Negotiations for US Manufacturing and Assembly Facilities for its Electric Vehicle Products
February 04, 2021 11:41 ET
|
DSG Global Inc.
SURREY, British Columbia, Feb. 04, 2021 (GLOBE NEWSWIRE) -- DSG Global, Inc. (OTCQB: DSGT) ("DSGT" or the "Company") is in active negotiations for multiple US manufacturing and assembly facilities...
Innovation Metals Corp. Provides Development Update on RapidSX™ Technology for Near-Term Commercial Rare-Earth Elements Separation in USA
February 01, 2021 11:08 ET
|
Innovation Metals Corp.
TORONTO, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Innovation Metals Corp. (“IMC” or the “Company”) is pleased to provide the following update regarding the Company’s ongoing commercialization development...
Immuron to Participate in H.C. Wainwright & Co. BioConnect 2021 Virtual Conference
January 11, 2021 06:00 ET
|
Immuron Limited
MELBOURNE, Australia, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercialising oral...
Immuron SARS-CoV-2 Research Agreement with Monash University
December 15, 2020 06:00 ET
|
Immuron Limited
Key Points Immuron’s Hyper-immune Bovine Colostrum, used to manufacture Travelan® and Protectyn®, demonstrated antiviral activity against the SARS-CoV-2/COVID-19 virus in laboratory studies.A New...
Immuron Receives AUD $358,280 R&D Tax Concession Refund
November 24, 2020 06:00 ET
|
Immuron Limited
MELBOURNE, Australia, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral...
US DoD Naval Medical Research Center Reports Positive Immunological Responses to Vaccine
November 11, 2020 06:00 ET
|
Immuron Limited
Key Points NMRC demonstrated functional antibodies in new oral therapeutic targeting Campylobacter and ETECImmuron executes a Research Agreement with PCI Clinical Services to manufacture drug...
Fluidigm to Present at Upcoming Health Care Investor Conference
November 10, 2020 08:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Innovation Metals Corp. Announces RapidSX™ Commercialization and Development Facility; Kingston Process Metallurgy Awarded Contract as RapidSX™ Laboratory Partner
June 23, 2020 14:08 ET
|
Innovation Metals Corp.
TORONTO, June 23, 2020 (GLOBE NEWSWIRE) -- Innovation Metals Corp. (“IMC” or the “Company”) is pleased to announce that the Company has executed a binding agreement with Kingston Process Metallurgy...
Immuron Partners with CSIRO to produce a new oral therapeutic for clinical evaluation by the US Department of Defense
June 19, 2020 06:00 ET
|
Immuron Limited
Key Points Immuron executes a Research Agreement with The Henry M. Jackson Foundation for Advancement of Military Medicine Inc.Immuron executes a Research Agreement with CSIRO to develop a new oral...
US DoD Naval Medical Research Center Requests Meeting with FDA for Guidance on two Phase 2 trials to Prevent Acute Infectious Diarrhea
June 09, 2020 06:00 ET
|
Immuron Limited
Key Points NMRC requests Pre-IND meeting with FDA on the development of a new oral therapeutic targeting Campylobacter and ETEC Two human phase II clinical trials to be conducted in 2021One trial...